GLP-1 Receptor Agonists Linked to Higher Ischemic Optic Neuropathy Risk in Type 2 Diabetes Patients
A recent observational study suggests a potential correlation between the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) in ... Read More